Search results
DeSantis says 'take your fake meat elsewhere' and signs bill banning lab-grown meat
Tallahassee Democrat· 3 days agoAt a press conference in Wauchula, Florida, DeSantis signed a bill that would outlaw the manufacture...
Jesse Malin Previews New Concert Film ‘Chasing the Light’ With Bad Brains Cover
Rolling Stone via Yahoo News· 23 hours agoHe’s currently undergoing physical therapy and stem-cell treatments at a clinic in Buenos Aires,...
'If he dies...' Fears raised over Mike Tyson 57, ahead of shock Jake Paul bout
The US Sun· 4 days agoJOE ROGAN has raised fears about Mike Tyson potentially DYING in his controversial clash with Jake...
Ozzy Osbourne Shares Health Update, Wants to Get Back on Stage
popculture.com· 2 days ago"I've just come back from the doctor after having some stem cells put in me," Osbourne told co-host...
Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
ETF DAILY NEWS· 9 hours agoEquities researchers at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued on Thursday. The brokerage set a “sell” rating ...
'Frankenstein' mice with brain cells from rats raised in the lab
Live Science via Yahoo News· 3 days agoMicroscopic image of mouse and rat brain cells shows cells labeled in red and blue on dark...
We Tested the Best Hair Loss Treatments That Combat Thinning
Men's Journal· 5 days agoNutrafol, Hims, and Vegamour are among the best hair loss treatments. Men’s Journal aims to feature...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 5 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
Health Care Heroes event to honor late Dr. William Henrich - San Antonio Business Journal
The Business Journals· 1 day agoThe San Antonio medical community lost a giant in March. Dr. William Henrich died of complications...
Mizuho Lowers Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $52.00
ETF DAILY NEWS· 3 days agoApellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its target price cut by analysts at Mizuho from $60.00 to $52.00 in a report released on Monday, Benzinga reports. Mizuho’s target ...